Butobarbital

Butobarbital, also called butobarbitone or butethal, Soneryl, and Neonal,^[1] is a hypnotic drug which is a barbiturate derivative.^[2] It was developed by Poulenc Brothers (now part of Sanofi) in 1921.^[3]

Trade namesSoneryl

AHFS/Drugs.comInternational Drug Names

Routes of
administrationBy mouth

ATC code

• N05CA03 (WHO)

Quick facts Clinical data, Trade names ...

Butobarbital

Clinical data
Trade names	Soneryl
AHFS/Drugs.com	International Drug Names
Routes of administration	By mouth
ATC code	N05CA03 (WHO)
Legal status
Legal status	AU: S8 (Controlled drug) CA: Schedule IV DE: Anlage II (Authorized trade only, not prescriptible)
Pharmacokinetic data
Metabolism	Liver
Excretion	Kidney
Identifiers
IUPAC name 5-Butyl-5-ethyl-1,3-diazinane-2,4,6-trione
CAS Number	77-28-1 Y
PubChem CID	6473
DrugBank	DB01353 Y
ChemSpider	6229 Y
UNII	OHZ8QAW6YC
KEGG	D02618 Y
ChEMBL	ChEMBL404422 Y
CompTox Dashboard (EPA)	DTXSID70227808
ECHA InfoCard	100.000.928
Chemical and physical data
Formula	C10H16N2O3
Molar mass	212.249 g·mol−1
3D model (JSmol)	Interactive image
SMILES O=C1NC(=O)NC(=O)C1(CCCC)CC
InChI InChI=1S/C10H16N2O3/c1-3-5-6-10(4-2)7(13)11-9(15)12-8(10)14/h3-6H2,1-2H3,(H2,11,12,13,14,15) Y Key:STDBAQMTJLUMFW-UHFFFAOYSA-N Y
(verify)

Close